Interdom-Lssp. z o.o.

Realization of building projects related to erection of buildings

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-12-27
Share capital
5,000.00 PLN
Registered address
pl. Wolności 15/4a, 35-074 Rzeszów, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed.

  • 2024not filed
  • 202310/06/2024
  • 202216/04/2023
  • 202130/05/2022
  • 202008/09/2021
  • 201924/06/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.

Division · Construction of buildings19,174 / 27,290
Top 70%
Sector · Construction21,668 / 30,475
Top 71%
Voivodeship · Podkarpackie12,387 / 16,365
Top 76%
Country · Poland369,299 / 495,935
Top 74%

Results vs industry

Revenue
This companyUSD 26.56kMedianUSD 139.70kAverageUSD 1.43m
Net profit
This companyUSD 19.15kMedianUSD 276.09AverageUSD 142.54k
Operating costs
This companyUSD 4.76kMedianUSD 105.89kAverageUSD 1.16m
Assets
This companyUSD 20.29kMedianUSD 497.28kAverageUSD 3.93m

Authorized Representatives

Leszek Jan Szpyrkaage 60 – President of the Management Board
Stanisław Kazimierz Pogodaage 65 – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
50$675.3150%
50$675.3150%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $1,690.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$136
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$136
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$136

FAQ

Last updated: 2026-04-21